BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21482735)

  • 41. IL-15 transpresentation augments CD8+ T cell activation and is required for optimal recall responses by central memory CD8+ T cells.
    Kokaji AI; Hockley DL; Kane KP
    J Immunol; 2008 Apr; 180(7):4391-401. PubMed ID: 18354159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+ T lymphocytes.
    Manders PM; Hunter PJ; Telaranta AI; Carr JM; Marshall JL; Carrasco M; Murakami Y; Palmowski MJ; Cerundolo V; Kaech SM; Ahmed R; Fearon DT
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7418-25. PubMed ID: 15833813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early life vaccination: Generation of adult-quality memory CD8+ T cells in infant mice using non-replicating adenoviral vectors.
    Nazerai L; Bassi MR; Uddback IE; Holst PJ; Christensen JP; Thomsen AR
    Sci Rep; 2016 Dec; 6():38666. PubMed ID: 27929135
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL-15-independent antiviral function of primary and memory CD8+ T cells.
    Zuo J; Stohlman SA; Bergmann CC
    Virology; 2005 Jan; 331(2):338-48. PubMed ID: 15629776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells.
    Intlekofer AM; Takemoto N; Kao C; Banerjee A; Schambach F; Northrop JK; Shen H; Wherry EJ; Reiner SL
    J Exp Med; 2007 Sep; 204(9):2015-21. PubMed ID: 17698591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human CD8+ T cell memory generation in Puumala hantavirus infection occurs after the acute phase and is associated with boosting of EBV-specific CD8+ memory T cells.
    Tuuminen T; Kekäläinen E; Mäkelä S; Ala-Houhala I; Ennis FA; Hedman K; Mustonen J; Vaheri A; Arstila TP
    J Immunol; 2007 Aug; 179(3):1988-95. PubMed ID: 17641066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses.
    Obar JJ; Molloy MJ; Jellison ER; Stoklasek TA; Zhang W; Usherwood EJ; Lefrançois L
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):193-8. PubMed ID: 19966302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IL-2 and IL-15 regulate CD8+ memory T-cell differentiation but are dispensable for protective recall responses.
    Mathieu C; Beltra JC; Charpentier T; Bourbonnais S; Di Santo JP; Lamarre A; Decaluwe H
    Eur J Immunol; 2015 Dec; 45(12):3324-38. PubMed ID: 26426795
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered ex vivo balance between CD28+ and CD28- cells within HIV-specific CD8+ T cells of HIV-seropositive patients.
    Dalod M; Sinet M; Deschemin JC; Fiorentino S; Venet A; Guillet JG
    Eur J Immunol; 1999 Jan; 29(1):38-44. PubMed ID: 9933084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.
    Williams MA; Tyznik AJ; Bevan MJ
    Nature; 2006 Jun; 441(7095):890-3. PubMed ID: 16778891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential interferon-γ production by naive and memory-like CD8 T cells.
    de Araújo-Souza PS; Hanschke SCH; Nardy AFFR; Sécca C; Oliveira-Vieira B; Silva KL; Soares-Lima SC; Viola JPB
    J Leukoc Biol; 2020 Oct; 108(4):1329-1337. PubMed ID: 32421902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Timing of Stimulation and IL-2 Signaling Regulate Secondary CD8 T Cell Responses.
    Khan SH; Martin MD; Starbeck-Miller GR; Xue HH; Harty JT; Badovinac VP
    PLoS Pathog; 2015 Oct; 11(10):e1005199. PubMed ID: 26431533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IL-15-Independent Maintenance of Tissue-Resident and Boosted Effector Memory CD8 T Cells.
    Schenkel JM; Fraser KA; Casey KA; Beura LK; Pauken KE; Vezys V; Masopust D
    J Immunol; 2016 May; 196(9):3920-6. PubMed ID: 27001957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction.
    Kastenmuller W; Gasteiger G; Subramanian N; Sparwasser T; Busch DH; Belkaid Y; Drexler I; Germain RN
    J Immunol; 2011 Sep; 187(6):3186-97. PubMed ID: 21849683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adenovirus vector vaccination reprograms pulmonary fibroblastic niches to support protective inflating memory CD8
    Cupovic J; Ring SS; Onder L; Colston JM; Lütge M; Cheng HW; De Martin A; Provine NM; Flatz L; Oxenius A; Scandella E; Krebs P; Engeler D; Klenerman P; Ludewig B
    Nat Immunol; 2021 Aug; 22(8):1042-1051. PubMed ID: 34267375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD8+ T Cell Fate and Function Influenced by Antigen-Specific Virus-Like Nanoparticles Co-Expressing Membrane Tethered IL-2.
    Wojta-Stremayr D; Neunkirchner A; Srinivasan B; Trapin D; Schmetterer KG; Pickl WF
    PLoS One; 2015; 10(5):e0126034. PubMed ID: 25946103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Quantity of Autocrine IL-2 Governs the Expansion Potential of CD8+ T Cells.
    Redeker A; Welten SP; Baert MR; Vloemans SA; Tiemessen MM; Staal FJ; Arens R
    J Immunol; 2015 Nov; 195(10):4792-801. PubMed ID: 26453748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cutting edge: CD4+ T cell-derived IL-2 is essential for help-dependent primary CD8+ T cell responses.
    Wilson EB; Livingstone AM
    J Immunol; 2008 Dec; 181(11):7445-8. PubMed ID: 19017930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2.
    Arenas-Ramirez N; Zou C; Popp S; Zingg D; Brannetti B; Wirth E; Calzascia T; Kovarik J; Sommer L; Zenke G; Woytschak J; Regnier CH; Katopodis A; Boyman O
    Sci Transl Med; 2016 Nov; 8(367):367ra166. PubMed ID: 27903862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T-bet-mediated differentiation of the activated CD8+ T cell.
    Yeo CJ; Fearon DT
    Eur J Immunol; 2011 Jan; 41(1):60-6. PubMed ID: 21182077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.